Immune pathways and genetic factors in SAPHO syndrome
Official title: Study of the Pathophysiological Mechanisms Involved in the SAPHO Syndrome: Genetic Component and Immune Response
Run by Fondation Hôpital Saint-Joseph · NCT07081880 · Data updated 2026-11-12
This project will test whether specific immune cell patterns and genetic differences in adults with SAPHO syndrome are linked to the disease by collecting blood and other biological samples.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Fondation Hôpital Saint-Joseph Academic / other |
| Locations | 2 sites (Paris and 1 other locations) |
| Status | Recruiting |
| Started | July 15, 2025 |
| Main results expected | July 15, 2028 |
| Study ends | May 15, 2035 |
| Registry record updated | December 24, 2025 |
| Trial ID | NCT07081880 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with a confirmed diagnosis of SAPHO syndrome who can give informed written consent, are French-speaking, weigh over 35 kg, and can attend the participating Paris hospitals.
✕Probably not a fit
Because this is an observational biological-sampling study, participants should not expect direct therapeutic benefit, and pregnant or breastfeeding people and those under legal protection are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will enroll adults with a confirmed diagnosis of SAPHO syndrome at two Paris hospitals to collect biological samples for laboratory study. Researchers will perform deep immune phenotyping of circulating leukocytes—focusing on neutrophil subsets, neutrophil extracellular traps (NETs), and Th17 cells—alongside protein profiling. The study will also conduct genetic analyses to search for variants associated with SAPHO in a European/Caucasian population, addressing gaps from prior smaller or non-European studies. Results will help identify over- or under-represented cell populations and candidate genes that may contribute to disease mechanisms.
Why it matters
Potential benefit: If successful, this work could identify clearer diagnostic markers and point to new targets for treatments tailored to people with SAPHO.
How similar studies have gone: Prior smaller studies have reported increased Th17 cells, low-density granulocytes, NET formation, and some genetic links (for example IL-23R and IL-4 in Chinese cohorts), but comprehensive circulating immune phenotyping and large-scale genetic analysis in European patients remain novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged ≥ 18 years * Patient diagnosed with SAPHO syndrome * Weight \> 35 kg * Patient affiliated with a health insurance plan * French-speaking patient * Patient who has given free, informed, and written consent Exclusion Criteria: * Patient under guardianship or curatorship * Patient deprived of liberty * Patient under legal protection * Pregnant or breastfeeding patient
Where it's running
-
Hôpital Cochin
Paris, France Recruiting -
Hôpital Paris Saint Joseph
Paris, France Recruiting
Study contacts
- Study coordinator: Olivier Fogel, MD
- Email: olivier.fogel@aphp.fr
- Phone: +331 58 41 13 70
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep patterns in psoriatic arthritis and SAPHO syndrome
This project will see how sleep problems, including breathing-related sleep disorders, occur in adults with psoriatic arthritis or SAPHO syndrome who need hospital sleep evaluation.
-
Treatment of SAPHO syndrome with Etanercept
This study is testing if the medication Etanercept can help adults with SAPHO syndrome who haven't found relief from other treatments.
-
How long to take two blood-thinning medicines after leg artery procedures in CLTI
This study tests whether a shorter course of dual antiplatelet therapy after below-the-knee artery revascularization helps people with chronic limb threatening ischemia.
-
Hypnosis to improve comfort during transoesophageal echocardiography
This trial will test whether conversational and brief hypnosis given by the cardiologist can make transoesophageal echocardiography easier and less uncomfortable for adults having the procedure with local anaesthetic.
-
Digital care-coordination support for family caregivers after an emergency-department discharge
This pilot tests whether the Monka digital app helps family caregivers of adults discharged from the emergency department reduce caregiver burden and improve post-discharge outcomes.
-
Music during nursing care to improve comfort after an acute stroke in the neurovascular ICU
We will see if playing music during nursing care helps adults hospitalized in the neurovascular ICU after an acute stroke feel more comfortable.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.